Jan. 14 at 1:24 PM
$VKTX
$NVO ceo talked about potential acquisitions, saying “ it could be 20 billion, it could be 30 billion, could be 40 billions. We could afford it, but it has to be worth it” and everyone thought immediately to
$VKTX
But I will tell you more.
What if he was talking also about
$BIOA that is in partnerships with bot
$NVO and
$LLY? Obviously they’re not gonna pay 10 billion right away, but looking at the potential of this company, the last month chart and share price and the interest around it, it would be unconsidered to not keep in consideration this company.
$BIOA has very promising data and they’re collaborating with two giants in a fight with each other for the first place in the obesity race.
The drug that this company is developing fight the muscle loss that is crucial in the weight loss process. They also deal with the inflammation data (obtained an 86% reduction in C-reactive protein) are considered the Gold Standard. I see a bright future ahead for
$BIOA in the nxt mont
